HealthVerity nets $25 million, plus more top funding news for Philadelphia-based companies

Philadelphia-based information technology and information services company HealthVerity has secured $25 million in Series C funding, according to company database Crunchbase, topping the city’s recent funding headlines. The cash infusion was announced April 3 and led by Foresite Capital.

According to its Crunchbase profile, "HealthVerity is a leading provider of technologies and software tools that enable health-care providers, such as pharmaceutical manufacturers, hospitals and payers, to discover, license and integrate patient data from a wide range of traditional and emerging data sources to build the optimal patient data set."

The five-year-old company has raised two previous funding rounds, including a $10 million Series B round in 2017.

The round brings total funding raised by Philadelphia companies in health care over the past month to $45 million. The local health-care industry has seen 30 funding rounds over the past year, raking in a total of $207 million in venture funding.

In other local funding news, therapeutics company Scout Bio announced a $20 million Series B funding round on April 10, led by RiverVest.

According to Crunchbase, "Scout Bio, (is) a Philadelphia, PA-based biotechnology company focused on innovating pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions."

The company also raised a $9.2 million Series A round in 2018.

This story was created automatically using local investment data, then reviewed by an editor. Click here for more about what we're doing. Got thoughts? Go here to share your feedback.